Djokovic has 80% stake in biotech firm developing Covid drug

The Guardian says Novak Djokovic is the controlling shareholder in a Danish biotech firm aiming to develop a treatment for Covid-19 that does not involve vaccination, it has emerged.

The world No 1, who was deported from Australia this week after the government cancelled his visa in a dispute over a medical exemption relating to his unvaccinated status, bought an 80% stake in QuantBioRes in 2020.

Ivan Loncarevic, the company’s chief executive, confirmed the investment to Reuters. He subsequently told the Financial Times that he had not spoken to Djokovic, who has won more than $150m in prize money, since November and that the tennis star was “not anti-vax”.

https://www.theguardian.com/sport/2022/jan/19/novak-djokovic-stake-biotech-firm-quantbiores-covid